Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
Authors
Keywords
Stage III colorectal cancer, Adjuvant chemotherapy, Capecitabine, FOLFOX, CAPOX, Baseline characteristics, Toxicity
Journal
MEDICAL ONCOLOGY
Volume 35, Issue 10, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-16
DOI
10.1007/s12032-018-1188-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
- (2016) Alexander Stein et al. BMC CANCER
- Possible Pathways of Capecitabine-Induced Hand–Foot Syndrome
- (2016) Yan Lou et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer
- (2016) Jenny J. Ko et al. Clinical Colorectal Cancer
- Intensity of adjuvant chemotherapy regimens and grade III–V toxicities among elderly stage III colon cancer patients
- (2016) F.N. van Erning et al. EUROPEAN JOURNAL OF CANCER
- Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens
- (2016) Raafi Ali et al. Cancer Medicine
- Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry
- (2015) Young Suk Park et al. Asia-Pacific Journal of Clinical Oncology
- Comparative Analysis of the Efficacy and Safety of Oxaliplatin Plus 5-Fluorouracil/Leucovorin (Modified FOLFOX6) with Advanced Gastric Cancer Patients having a Good or Poor Performance Status
- (2015) Ilhan Hacibekiroglu et al. Asian Pacific Journal of Cancer Prevention
- The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
- (2015) M. Ozcelik et al. Clinical & Translational Oncology
- Anemia and Functional Disability in Older Adults With Cancer
- (2015) Cynthia Owusu et al. Journal of the National Comprehensive Cancer Network
- T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy
- (2015) Min An et al. World Journal of Surgical Oncology
- Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience
- (2014) Christina A.K. Kim et al. Clinical Colorectal Cancer
- CAPOX Associated With Toxicities of Higher Grade but Improved Disease-Free Survival When Compared With FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer
- (2014) Jonathan M. Loree et al. Clinical Colorectal Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Pre-operative anaemia in colon cancer patients became normal after more than a year post-operatively but did not influence oncological outcome in the final analysis
- (2013) Ingrid Fjørtoft et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
- (2012) R-D Hofheinz et al. BRITISH JOURNAL OF CANCER
- Safety and Effectiveness of Oxaliplatin-Based Chemotherapy Regimens in Adults 75 Years and Older With Colorectal Cancer
- (2012) Nadine Jackson McCleary et al. Clinical Colorectal Cancer
- Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
- (2011) Kyung Kee Baek et al. Cancer Research and Treatment
- Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer
- (2010) Eduard Vrdoljak et al. ANTI-CANCER DRUGS
- Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis
- (2009) G. Zhao et al. Colorectal Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search